Paula Rocha

Paula Rocha

Auto-generated profile, based on publicly available information

Paula Rocha

Pediatrics Unit. Dona Estefânia Hospital. Unidade Local de São José. Lisbon. & NOVA Medical School. Universidade NOVA de Lisboa. Lisbon. Portugal

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2019 in Clinical Pediatrics
Verified
Journal Article
Closed access
PDF file
ARAna Paula Rocha
Ana Paula Rocha
TSTiago Milheiro Silva
Tiago Milheiro Silva
TFTelma Francisco
Telma Francisco
CNConceição Neves
Conceição Neves
VBVera Brites
Vera Brites
FCFlora Candeias
Flora Candeias

29 November 2024 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
JSJoão Ferreira Simões
João Ferreira Simões
MSMargarida Simão
Margarida Simão
PRPaula Rocha
Paula Rocha
SFSara Ferreira
Sara Ferreira
RCRosário Perry da Câmara
Rosário Perry da Câmara
MCMário Coelho
Mário Coelho
Neonatal hyperbilirubinaemia is more common in Asian-descendent populations, but differences in disease severity are poorly reported. Our study aimed to compare neonatal hyperbilirubinaemia severity between European and Indian subcontinent descendent newborns. We conducted a single-centre retrospective cohort study including newborns admitted with unconjugated hyperbilirubinaemia (January 2016 to December 2021). Patients were followed during admission, comparing those with European ancestry (control group) and Indian subcontinent ancestry (India, Pakistan, Bangladesh and Nepal) (study group). The primary outcome was severe hyperbilirubinemia (TSB > 25 mg/dL, phototherapy > 6 h or need for exchange transfusion [ET]), and the secondary was TSB levels. Adjusted analysis for potential confounding factors was performed using binary logistic regression models. Of 110 newborns included, 27 (24.5%) had Indian subcontinent ancestry. Occurrence of TSB > 25 mg/dL was significantly higher in the study group (22.2% vs. 4.8%, p = 0.006), while no differences were noted in exposure to phototherapy > 6 h and ET therapy. Logistic regression models for confounding factors adjustment showed Indian subcontinent ancestry as an independent risk factor for TSB > 25 mg/dL (OR 7.49, CI 95% [1.23–45.50]). The study group revealed also higher absolute values of TSB both at admission (22.0 mg/dL vs. 19.6 mg/dL, p = 0.013) and at discharge (13.6 mg/dL vs. 11.4 mg/dL, p = 0.005). Conclusion: Our findings suggest that newborns with Indian subcontinent ancestry might show a higher risk for the development of severe hyperbilirubinemia compared to European ancestry newborns. Implementing earlier treatment thresholds in this subset of patients may help prevent severe hyperbilirubinemia. What is Known:• Indian subcontinent descendent populations have high incidence of neonatal hyperbilirubinaemia but data regarding its severity are scarce. What is New:• This article shows that, compared to European descendent newborns, Indian subcontinent descendent newborns might be at higher risk for severe hyperbilirubinaemia.

28 February 2019 in Acta Medica Portuguesa
Verified
Journal Article
Open access
PDF file
ARAna Paula Rocha
Ana Paula Rocha
MBMadalena Borges
Madalena Borges
CNConceição Neves
Conceição Neves
JNJoão Farela Neves
João Farela Neves
We report a case of an 18-month-old boy with H factor deficiency with atypical presentation: recurrent acute otitis media and several maternal family members with autoimmune disorders (vitiligo, thyroiditis and immune trombocytopenia). Blood tests revealed low C3 and AH50, as well as low properdin and H factor. I factor was normal. CFH gene molecular test confirmed the H factor deficiency diagnosis. This child had none of the typical manifestations of this disorder, namely Neisseria meningitidis infection or renal disease (glomerulonephritis and atypical haemolytic uremic syndrome). Autoimmune family history and correct interpretation of blood tests’ results were crucial for this diagnosis.

1 January 2019 in Revista De Neurologia
Verified
Journal Article
Closed access
ARAna Paula Seabra de Almeida Carmo Rocha
Ana Paula Seabra de Almeida Carmo Rocha
MCMaria Flora Candeias
Maria Flora Candeias
CCCarla Maria Ribeiro de Conceição
Carla Maria Ribeiro de Conceição
JVJosé Pedro Vieira
José Pedro Vieira
MBMaria João Rocha Brito
Maria João Rocha Brito

11 June 2025 in Innovative Journal of Pediatrics
Verified
Journal Article
Open access
RARosa Amorim-Figueiredo
Rosa Amorim-Figueiredo
RNRaquel da Costa Neves
Raquel da Costa Neves
JSJoao Simoes
Joao Simoes
MSMargarida Simão
Margarida Simão
RDRui Domingues
Rui Domingues
RARosa Amorim-Figueiredo
Rosa Amorim-Figueiredo
Background: It was unknown if respiratory syncytial virus (RSV) severity changed during the COVID-19 pandemic, as previous studies presented conflicting results. It is important to understand if RSV severity is affected by viral pandemics to determine the choice of the most suitable RSV prophylactic measures. Objectives: The full characterization of the pediatric RSV hospitalized population before and during the COVID-19 pandemic, searching for changes in RSV severity. Risk factors for severe RSV disease were also analyzed. Methods: A retrospective cohort study of the RSV patients admitted to a tertiary pediatric hospital between January 2017 and March 2022. The primary outcome was the need for high-flow (HF) oxygen therapy before and during the COVID-19 pandemic. Other analyzed data included age, gender, prematurity, comorbidities, reason for admission, viral coinfections, bacterial superinfection, low-flow oxygen, non-invasive and mechanical ventilation (MV), admission to the pediatric intensive care unit (PICU), and length of stay. Results: During the COVID-19 pandemic, a slight increase in severity was observed, as the need for HF increased (P = 0.001, adjusted-P = 0.008). There was also an increase in the proportion of RSV hospitalized patients aged 24 months or older (P = 0.002, adjusted-P = 0.015). There were no differences regarding the length of stay, gender, prematurity, chronic disease, reasons for admission, bacterial superinfection, viral coinfections, admission to the PICU, low-flow oxygen therapy, non-invasive ventilation (NIV), or MV. Conclusions: Our study clarified the impact of the COVID-19 pandemic on RSV severity and found an age shift in the RSV burden during the pandemic. We concluded that RSV severity may have been affected by the COVID-19 pandemic. Since RSV severity changes with viral pandemics, it is important to continue monitoring RSV epidemiology to choose the best RSV prophylactic method, such as palivizumab or nirsevimab for infants and the RSV vaccine for pregnant women, considering the birth date of the baby, RSV seasonality, and RSV severity of that season.

1 October 2025 in Acta Medica Portuguesa
Verified
Journal Article
Open access
PDF file
RNRaquel Da Costa Neves
Raquel Da Costa Neves
AGAna Luísa Gouveia
Ana Luísa Gouveia
CMClara Marecos
Clara Marecos
SJSandra Jacinto
Sandra Jacinto
PRPaula Rocha
Paula Rocha